COVID-19 booster discussions have led to a 'communications crisis' and 'nonstop' phone calls


The back-and-forth on COVID-19 booster shots among the Food and Drug Administration, the Centers for Disease Control and Prevention, and their advisory panels amounts to a "communications crisis," Robert Murphy, the executive director of the Institute for Global Health at Northwestern University Feinberg School of Medicine, told The Washington Post.
Many Americans seem like they aren't sure if they're eligible for a third dose of the Pfizer-BioNTech vaccine (the only one of the three available shots that's received formal discussions on boosters) because of hard-to-follow guidance from public health officials — first, the CDC advisory panel narrowed the FDA panel's initial recommendation, and then CDC Director Rochelle Walensky overruled that, broadening it again.
The situation, though, has led to a deluge of phone calls to healthcare providers at the local level. For instance, a customer service representative for Primary Health clinics in southwestern Idaho told the Post "the calls seem pretty nonstop." David Peterman, Primary Health's chief executive, said in light of the booster confusion "we went from 40,000 phone calls daily to 80,000," prompting him to ask staffers to take extra shifts.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Jay A. Winsten, the founding director of the Center for Health Communications at the Harvard T.H. Chan School of Public Health, thinks the solution should come from the top. While the FDA and CDC have a lot of experts in the health and science fields, "what's missing from the equation are communication experts," Winsten said, adding that "they need a seat at the table." Read more at The Washington Post.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Labubu: the 'creepy' dolls sparking brawls in the shops
Craze for the pint-sized soft toys has reached fever pitch among devotees
-
The top period dramas to stream now
The Week Recommends Heaving bosoms and billowing shirts are standard fare in these historical TV classics
-
Women need more pain management during gynecological procedures
Under the radar Pain should no longer be ignored
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
Unraveling autism: RFK Jr.'s vow to find a root cause
Feature RFK Jr. has vowed to find the root cause of the 'autism epidemic' in months. Scientists have doubts.
-
The sneaking rise of whooping cough
Under the Radar The measles outbreak isn't the only one to worry about
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia